GlassScriptPhysician profile
Shakeel Modak
NPI 1063483535
$64,402.44
in general payments reported to CMS, 2019-2025
7 companies · $5,388 in 2025
The $5,388 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,541 · 2020: $49K · 2021: $1,800 · 2022: $3,939 · 2023: $60.00 · 2024: $2,175 · 2025: $5,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,455 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $105 · Food and Beverage: $62.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,455.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105.00 |
| Food and Beverage | $62.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $48,500.00 | 2020 | |
| Emd Serono Research & Development Institute, INC. | $7,455.00 | 2024-2025 | |
| Y-Mabs Therapeutics, INC. | $3,112.90 | 2021-2025 | Danyelza |
| Uswm, LLC | $2,688.96 | 2022 | |
| Progenics Pharmaceuticals, INC. | $2,540.58 | 2019 | |
| Partner Therapeutics, INC. | $105.00 | 2023-2024 | Leukine |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shakeel Modak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.